- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05638412
Investigating the Impact of JASPER Behavioral Therapy in Children With Down Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Down syndrome (DS), the most common genetic cause of intellectual disability, can be associated with a wide range of developmental needs. Behavioral challenges are common, and can impact learning, overall achievement, relationships, inclusion in schools, and community integration.
The goal of this study is to determine whether JASPER (Joint Attention Symbolic Play Engagement and Regulation) can improve caregiver implementation of behavioral strategies, caregiver self-efficacy and confidence, and child development.
Participants will be randomized to receive either the JASPER intervention or a caregiver psychoeducational group. Participants in the JASPER intervention will receive 10 weekly virtual educational sessions utilizing JASPER therapy modules through 1:1 parent-child coaching sessions. Caregivers in the comparison group will receive 10 weekly modules containing a psychoeducational curriculum. The outcome measures will assess caregiver responsiveness, child joint engagement with caregiver, caregiver self-efficacy, and child behavior, language, and adaptive skills.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02445
- Boston Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Confirmed diagnosis of Trisomy 21
- Age 3-7 years
- Able to walk independently
- English speaking
- Caregiver able to complete either 1:1 virtual coaching sessions or psychoeducational behavioral curriculum
Exclusion Criteria:
- Mosaic Down syndrome
- Significant and uncorrected hearing and/or vision problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: JASPER Intervention Group
Caregivers receiving the JASPER intervention will undergo weekly virtual 60-minute sessions for 10 weeks conducted via Zoom. The content of the intervention includes teaching and implementation of contingent responding and specific strategies to provide a high-quality response to children's communication, and play behaviors. Caregiver training is completed through review of pre-recorded videos of the caregiver-child dyad each week. The first half of each session will be dedicated to reviewing previous content and feedback on the play recording. The following half will consist of new material. The coaching support includes contingent responding, the parent is also taught to use specific strategies to provide a rich, high-quality response to children's communication, and play behaviors. |
JASPER is a therapist and caregiver-mediated intervention that (1) targets the foundations of social communication, (2) uses naturalistic behavioral strategies to increase the rate and complexity of social communication and (3) includes caregivers as implementers of the intervention to promote generalization across settings and to ensure maintenance.
This intervention is individualized and centered around two key developmental domains critical for social communication function: joint engagement and joint attention.
|
|
Experimental: Psychoeducational Curriculum Group
Caregivers receiving the 10 weekly psychoeducational curriculum modules will be provided with the resources via secure email and encouraged to engage with the material a self-directed manner. The psychoeducational modules will include written information about child development, communication and social interaction skills, behavioral principles for managing challenging behavior and strategies for teaching new skills. No direct caregiver-child mediated coaching will be provided. The content of the modules will include information about developmental milestones in this age group for children with DS, behavior management strategy recommendations, positive parenting materials, and materials on increasing engagement through play. |
The psychoeducational modules will include written information about child development, communication and social interaction skills, behavioral principles for managing challenging behavior and strategies for teaching new skills.
No direct caregiver-child mediated coaching will be provided.
The material provided will be similar to what a pediatrician or developmental specialist may review as a part of routine care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Joint engagement and joint attention skills
Time Frame: 20 weeks
|
Joint engagement and joint attention skills will be coded from Caregiver-Child Interaction (CCX) video recordings.
The 15-minute CCX videos measure the amount of time that caregiver and child engage during a play session.
The frequency of the child's engagement states will be coded using an Engagement State Coding Scheme to measure proportion of video during which child is maintaining Joint Engagement (shared engagement in a play routine).
|
20 weeks
|
|
Caregiver use of behavioral strategies
Time Frame: 20 weeks
|
The frequency with which caregivers use behavioral strategies will be collected from a weekly caregiver Behavioral Strategy Log.
|
20 weeks
|
|
Language, socialization, play, problem behavior, and adaptive skills
Time Frame: 20 weeks
|
Language, socialization, play, problem behavior, and adaptive skills measured by a parent interview about development using the Vineland Adaptive Behavior Scales (VABS-III).
Behavior frequency is measured on a range of 0=Never to 1=Sometimes to 2=Usually.
|
20 weeks
|
|
Social communication skills
Time Frame: 20 weeks
|
Social communication skills will be coded from Caregiver-Child Interaction (CCX) video recordings.
The 15-minute CCX videos measure the amount of time that caregiver and child engage during a play session.
A Social Communication Coding Scheme will measure the child's social communication skills.
This coding scheme includes various social communication items and "Yes" or "No" codes to measure social communication skill development over time.
Increasing answers of "Yes" indicate growth in social communication skills.
|
20 weeks
|
|
Socialization and play skills
Time Frame: 20 weeks
|
Socialization and play skill development measured by the Play Assessment Questionnaire.
The Play Assessment Questionnaire includes "Yes" or "No" items about play skills, symbolic play types and routines, and play level.
This caregiver questionnaire measures play skill development over time.
Increasing answers of "Yes" indicate growth in play skills.
|
20 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Genetic Diseases, Inborn
- Neurobehavioral Manifestations
- Congenital Abnormalities
- Abnormalities, Multiple
- Intellectual Disability
- Chromosome Disorders
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Behavior
- Social Behavior
- Self-Control
- Down Syndrome
- Communication
- Emotional Regulation
- Dentistry
- Orthodontic Appliances, Functional
- Orthodontic Appliances
- Orthodontics
- Orthodontic Appliances, Removable
- Activator Appliances
Other Study ID Numbers
- P00043317
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
University of Nevada, Las VegasRecruiting
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
-
Cairo UniversityCompleted
Clinical Trials on JASPER
-
University of California, Los AngelesCompleted
-
Boston Children's HospitalCompleted
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
University of California, Los AngelesSimons FoundationCompletedAutism Spectrum DisorderUnited States
-
University of California, Los AngelesUniversity of Massachusetts, WorcesterRecruiting
-
Boston University Charles River CampusUniversity of California, Los Angeles; University of Chicago; Boston Medical... and other collaboratorsActive, not recruiting
-
Vanderbilt UniversityUniversity of California, Los AngelesCompletedDown Syndrome | Language ImpairmentUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)CompletedAutism Spectrum DisorderUnited States
-
University of California, Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsUnknown
-
University of California, Los AngelesBoston Children's HospitalCompletedTuberous Sclerosis ComplexUnited States